In contrast, IL-4-treated macrophages (M2-type) promoted the growth of tumor cells, and lower dose (1 μM) of CHA could significantly inhibit the M2 macrophages-induced proliferation of glioma and breast cancer cells. Here, IL4 is linked to glioma.